Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Skaper

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Neurochemical Research|June 27, 2009
Oligodendrocytes are a novel source of amyloid peptide generationStephen D Skaper, Nicholas A Evans, Nicholas A Evans, et al.
Inflammopharmacology|November 2, 2013
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic painStephen D Skaper, Laura Facci, Mariella Fusco, et al.
CNS & Neurological Disorders Drug Targets|July 12, 2014
A novel prion protein-tyrosine hydroxylase interactionMattia Vicario, Adriana Zagari, Vincenzo Granata, et al.
Neurobiology of Disease|March 4, 2008
Generation of a alpha-synuclein-based rat model of Parkinson's diseaseAlessandra Recchia, David Rota, Patrizia Debetto, et al.
Molecular Neurobiology|June 10, 2015
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of ResolutionStephen D Skaper, Laura Facci, Massimo Barbierato, et al.
Inflammopharmacology|May 28, 2014
Reply to: "Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives" Inflammopharmacology DOI:10.1007/s10787-014-0202-3Stephen D Skaper, Laura Facci, Mariella Fusco, et al.
CNS & Neurological Disorders Drug Targets|September 6, 2016
Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for NeuroprotectionHari Shanker Sharma, Dafin F Muresanu, José V Lafuente, et al.
Pain and Therapy|March 30, 2018
A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A ReviewGiustino Varrassi, Mariella Fusco, Stephen D Skaper, et al.
Neuroreport|September 17, 2004
A novel somatodendritic marker defined by a peptide derived from the ALS2 proteinVirginie Bros, Stephen J A Shemilt, Jonathan D Cooper, et al.
Journal of Neuroinflammation|December 31, 2015
Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytesCarla Marinelli, Rosa Di Liddo, Laura Facci, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Neurochemical Research|June 27, 2009
Oligodendrocytes are a novel source of amyloid peptide generationStephen D Skaper, Nicholas A Evans, Nicholas A Evans, et al.
Inflammopharmacology|November 2, 2013
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic painStephen D Skaper, Laura Facci, Mariella Fusco, et al.
CNS & Neurological Disorders Drug Targets|July 12, 2014
A novel prion protein-tyrosine hydroxylase interactionMattia Vicario, Adriana Zagari, Vincenzo Granata, et al.
Neurobiology of Disease|March 4, 2008
Generation of a alpha-synuclein-based rat model of Parkinson's diseaseAlessandra Recchia, David Rota, Patrizia Debetto, et al.
Molecular Neurobiology|June 10, 2015
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of ResolutionStephen D Skaper, Laura Facci, Massimo Barbierato, et al.
Inflammopharmacology|May 28, 2014
Reply to: "Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives" Inflammopharmacology DOI:10.1007/s10787-014-0202-3Stephen D Skaper, Laura Facci, Mariella Fusco, et al.
CNS & Neurological Disorders Drug Targets|September 6, 2016
Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for NeuroprotectionHari Shanker Sharma, Dafin F Muresanu, José V Lafuente, et al.
Pain and Therapy|March 30, 2018
A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A ReviewGiustino Varrassi, Mariella Fusco, Stephen D Skaper, et al.
Neuroreport|September 17, 2004
A novel somatodendritic marker defined by a peptide derived from the ALS2 proteinVirginie Bros, Stephen J A Shemilt, Jonathan D Cooper, et al.
Journal of Neuroinflammation|December 31, 2015
Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytesCarla Marinelli, Rosa Di Liddo, Laura Facci, et al.
Pageof 10